Caregivers of Participants with GI/GU/Lymphoma CancerActiveComparator Group · 2 Interventions: Consumer Assessment of Health Care Providers and Systems Program (CAHPS), The Consultation and Relational Empathy (CARE) questionnaire · Intervention Types: Behavioral, Behavioral
Participants with GI/GU/Lymphoma CancerActiveComparator Group · 3 Interventions: Consumer Assessment of Health Care Providers and Systems Program (CAHPS), Patient activation measure (PAM) scale, The Consultation and Relational Empathy (CARE) questionnaire · Intervention Types: Behavioral, Behavioral, Behavioral
Screening: ~3 weeks
Reporting: 8 weeks
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,821 Previous Clinical Trials
584,259 Total Patients Enrolled
148 Trials studying Lymphoma
7,724 Patients Enrolled for Lymphoma
Smita Banerjee, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
4 Previous Clinical Trials
1,365 Total Patients Enrolled
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:
You are willing to be audio-recorded as per self-report.
You are aged 65 years or over, and you have had a new visit within the last 6 months.
You are a woman aged 65 years or over.
You are seen by one of the consented HCPs as per the HCP and/or EMR.
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.